Eosinophil-derived neurotoxin in childhood asthma: Correlation with disease severity

Journal of Asthma

Volumn 47, Issue 5, 2010, Pages 568-573

  Kim, Chang Keun ^a   Callaway, Zak ^a   Fletcher, Rachel ^a   Koh, Young Yull ^b  

^a Inje University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Biomarker; Blood eosinophil; Childhood asthma; Eosinophil cationic protein; Eosinophil derived neurotoxin

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL PROTEIN X; METHYLPREDNISOLONE; PREDNISOLONE; SALBUTAMOL;

ACUTE DISEASE; ARTICLE; ASTHMA; CHILD; CHILD HEALTH; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE MARKER; DISEASE SEVERITY; EOSINOPHIL COUNT; FEMALE; HUMAN; MALE; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SYMPTOMATOLOGY;

ASTHMA; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL-DERIVED NEUROTOXIN; FEMALE; HUMANS; INFANT; MALE; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 77953867912     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770901003792833     Document Type: Article

References (36)

1. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323:1033-1039.
2. Ohashi Y, Motojima S, Fukuda T, Makino S. Airway hyperresponsiveness, increased intracellular spaces of bronchial epithelium, and increased infiltration of eosinophils and lymphocytes in bronchial mucosa in asthma. Am Rev Respir Dis 1992; 145:1469-1476.
3. Wardlaw AJ, Brightling C, Green R, Woltmann G, Pavord I. Eosinophils in asthma and other allergic diseases. Br Med Bull 2000; 56:985-1003.
4. Leckie M, Brinke A, Khan J, Diamant Z, O'Connor BJ, Walls CM, et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000; 356:2144-2148.
5. Flood-Page PT, Menzies-Gow AN, Kay AB, Robinson DS. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med 2003; 167:199-204.
6. Haldar P, Brightling CE, Hargadon B, Gupta S,MonteiroW, Sousa A, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009; 360:973-984.
7. Nair P, Pizzichini MM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, Hargreave FE, O'Byrne PM. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009; 360:985-993.
8. Gleich GJ, Adolphson CR. The eosinophil and bronchial asthma: evidence for a critical role of eosinophils in pathophysiology. In: Sanderson CJ, ed. Interleukin-5: From Molecule to Drug Target for Asthma. Lung Biology in Health and Disease. New York: Marcel Dekker, Inc., 1999:1-37.
9. Venge P, Bystrom J, Carlson M, Hakansson L, Karawacjzyk M, Peterson C, Seveus L, Trulson A. Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as amarker of eosinophil activation in disease. Clin Exp Allergy 1999; 29:1172-1186.
10. Bergstrand H, Lundquist B, Petersson B, Peterson CG, Venge P. Eosinophil derived cationic protein and human leukocyte histamine release. In: Venge P, Lindblom A, eds. Inflammation: BasicMechanisms Tissue Injuring Principles and Clinical Models. Stockholm: Almqvist & Wiksell International, 1985:361-365.
11. Chihara J, Urayama O, Tsuda A, Kakazu T, Higashimoto I, Yamada H. Eosinophil cationic protein induces insulin-like growth factor I receptor expression on bronchial epithelial cells. Int Arch Allergy Immunol 1996; 111:43-45.
12. Moqbel R, Lace P, Adamko DJ, Odemuyiwa SO. Biology of eosinophils. In: Adkinson NF Jr, Bochner BS, Busse WW, Holgate ST, Lemanske RF Jr, Simons FER, eds. Allergy: Principles & Practice. St. Louis: Mosby, 2008:295-310.
13. Kim KW, Lee KE, Kim ES, Song TW, Sohn MH, Kim KE. Serum eosinophil-derived neurotoxin (EDN) in diagnosis and evaluation of severity and bronchial hyperresponsiveness in childhood asthma. Lung 2007; 185:97-103.
14. Koller DY, Halmerbauer G, Frischer T, Roithner B. Assessment of eosinophil granule proteins in various body fluids: is there a relation to clinical variables in childhood asthma?Clin ExpAllergy 1999; 29:786-793.
15. Global Initiative for Asthma (GINA). Global Strategy for the Diagnosis and Management of Asthma in Children 5 Years and Younger. 2009. Available at: http://www.ginasthma.org.
16. Morioka J, Kurosawa M, Inamura H, Nakagami R, Mizushima Y, Chihara J, Yokoseki T, Kitamura S, Omura Y, Shibata M. Development of a novel enzyme-linked immunosorbent assay for blood and urinary eosinophilderived neurotoxin: a preliminary study in patients with bronchial asthma. Int Arch Allergy Immunol 2000; 122:49-57.
17. Parkin PC, Macarthur C, Saunders MR, Diamond SA,Winders PM. Development of a clinical asthma score for use in hospitalized children between 1 and 5 years of age. J Clin Epidemiol 1996; 49:821-825.
18. Venge P. Monitoring the allergic inflammation. Allergy 2004; 59:26-32.
19. Taniuchi S, Chihara J, Kojima T, Yamamoto A, Sasai M, Kobayashi Y. Serum eosinophil derived neurotoxin may reflect more strongly disease severity in childhood atopic dermatitis than eosinophil cationic protein. J Dermatol Sci 2001; 26:79-82.
20. Lugosi E, Halmerbauer G, Frischer T, Koller DY. Urinary eosinophil protein X in relation to disease activity in childhood asthma. Allergy 1997; 52:584-588. (Pubitemid 27308752)
21. Kristjannson S, Strannegard IL, Strannegard O, Perterson C, Enander I, WennergrenG.Urinary eosinophil proteinXin childrenwith atopic asthma: a useful marker of anti-inflammatory treatment. J Allergy Clin Immunol 1996; 97:1179-1187.
22. Goto T, Morioka J, Inamura H, Yano M, Kodaira K, Igarashi Y, Abe S, Kurosawa M. Urinary eosinophil-derived neurotoxin concentrations in patients with atopic dermatitis: a useful clinical marker for disease activity. Allergol Int 2007; 56:433-438.
23. Tauber E, Halmerbauer G, Frischer T, Gartner C, Horak F Jr, Veiter A, Koller DY, StudnickaM. Urinary eosinophil protein X in children: the relationship to asthma and atopy and normal values. Allergy 2000; 55:647-652.
24. Wojnarowski C, Roithner B, Koller DY, Halmerbauer G, Gartner C, Tauber E, Frischer T. Lack of relationship between eosinophil cationic protein and eosinophil protein X in nasal lavage and urine and the severity of childhood asthma in a 6-month follow-up study. Clin Exp Allergy 1999; 29:926-932.
25. Wolthers OD. Eosinophil granule proteins in the assessment of airway inflammation in pediatric bronchial asthma. Pediatr Allergy Immunol 2003; 14:248-254.
26. Remes S, Korppi M, Remes K, Savolainen K, Mononen I, Pekkanen J. Serum eosinophil cationic protein (ECP) and eosinophil protein X (EPX) in childhood asthma: the influence of atopy. Pediatr Pulmonol 1998; 25:167-174.
27. Gleich GJ, Adolphson CR. The eosinophilic leukocyte: structure and function. Adv Immunol 1986; 39:177-253.
28. Sedgwick JB,Vrtis RF, JansenKJ, Kita H, Bartemes K, BusseWW.Peripheral blood eosinophils from patients with allergic asthma contain increased intracellular eosinophil-derived neurotoxin. J Allergy Clin Immunol 2004; 114:568-574.
29. Pronk-Admiraal CJ, Bartels PC. Scand J Clin Lab Invest 2001; 61:453-457.
30. Abu-Ghazaleh RI, Dunnette SL, Loegering DA, Checkel JL, Kita H, Thomas LL, Gleich GJ. Eosinophil granule proteins in peripheral blood granulocytes. J Leukoc Biol 1992; 52:611-618.
31. Pizzichini E, Pizzichini MM, Efthimiadis A, Dolovich J, Hargreave FE. Measuring airway inflammation in asthma: eosinophils and eosinophilic cationic protein in induced sputum compared with peripheral blood. J Allergy Clin Immunol 1997; 99:539-544. (Pubitemid 27173093)
32. Scher H, Berman D, Weinberg EG, Schinkel M, Peper B, Chalton DO, Potter PC. Granulocyte proteins in serum in childhood asthma: relation to spirometry and therapy. Clin Exp Allergy 1996; 26:1131-1141.
33. Meijer RJ, Kerstjens HA, Arends LR, Kauffman HF, Koeter GH, Postma DS. Effects of inhaled fluticasone and oral prednisolone on clinical and inflammatory parameters in patients with asthma. Thorax 1999; 54:894-899.
34. Winqvist I, Olofsson T, Olsson I. Mechanisms for eosinophil degranulation: release of the eosinophil cationic protein. Immunology 1984; 51: 1-8.
35. Kita H, Abu-Ghazaleh R, Sanderson CJ, Gleich GJ. Effect of steroids on immunoglobulin-induced eosinophil degranulation. J Allergy Clin Immunol 1991; 87:70-77.
36. Gleeson JG, Loftus BG, Price JF. Placebo controlled trial of systemic corticosteroids in acute childhood asthma. Acta Paediatr Scand 1990; 79:1052-1058.